Press Release: HiFiBiO : Fierce Biotech Names HiFiBiO Therapeutics a "Fierce 15" Biotech Company of 2023

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biotech--HiFiBiO Therapeutics, a clinical stage global biotech company focusing on improving patient lives with single cell precision, today announced that Fierce Biotech has named it as one of 2023's "Fierce 15" biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. "HiFiBiO Therapeutics is at the forefront of harnessing single-cell insights to bring innovative immunomodulatory